Nuwellis Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral Catheter
Specialty catheter provides alternative peripheral access for ultrafiltration therapy across a greater range of patient physiologiesMINNEAPOLIS, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced it has received U.S. Food and Drug Administration (FDA) clearance for its specialty peripheral dual lumen extended length catheter (dELC). The addition of a new 12 cm catheter prov
Source: yahoo.com
